Salmeterol Export Market Intelligence: India's 148 Suppliers Shipping to 90 Countries — TransData Nexus 2026

Q: Who are the top salmeterol exporters from India?

The top salmeterol exporters from India are: 1. CIPLA LIMITED — $55.7M (76.5% market share); 2. HETERO LABS LIMITED — $6.4M (8.8% market share); 3. MEDISPRAY LABORATORIES PRIVATE LIMITED — $3.1M (4.3% market share); 4. ZYDUS LIFESCIENCES LIMITED — $1.1M (1.5% market share); 5. VAMSI PHARMA PRIVATE LIMITED — $1.1M (1.5% market share). Together they account for 92.5% of India's total salmeterol export value.

Q: What is the total export value of salmeterol from India?

The total export value of salmeterol from India is $72.8M USD, recorded across 7,006 shipment transactions from 148 active exporters to 90 destination countries. The average shipment value is $10.4K.

Q: Which countries import salmeterol from India?

India exports salmeterol to 90 countries worldwide. The top importing countries are: CHILE (13.4% share, $9.7M), TURKEY (10.8% share, $7.9M), AUSTRALIA (10.5% share, $7.6M), MOROCCO (8.0% share, $5.8M), BELGIUM (7.1% share, $5.2M). These five markets account for 49.9% of total export value.

Q: What is the HS code for salmeterol exports from India?

The primary HS code for salmeterol exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of salmeterol exports from India?

The average unit price for salmeterol exports from India is $18.14 USD per unit, with prices ranging from $0.01 to $3871.76 depending on formulation, packaging, and order volume. The total market is valued at $72.8M across 7,006 shipments.

Q: Which ports handle salmeterol exports from India?

The primary ports for salmeterol exports from India are DELHI AIR CARGO ACC (INDEL4) (20.4% of shipments), SAHAR AIR (18.2% of shipments), DELHI AIR (16.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (9.0% of shipments), NHAVA SHEVA SEA (INNSA1) (5.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of salmeterol?

India is one of the world's leading exporters of salmeterol due to its large base of 148 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports salmeterol to 90 countries, demonstrating 46% global market coverage.

Q: What certifications do Indian salmeterol exporters need?

Indian salmeterol exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import salmeterol from India?

There are 370 registered buyers importing salmeterol from India, spread across 90 countries. The repeat buyer rate is 69.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top salmeterol supplier from India?

CIPLA LIMITED is the leading salmeterol exporter from India with a market share of 76.5% and total export value of $55.7M across 1265 shipments. The top 5 suppliers together control 92.5% of total export value.

Suresh Sormare

Salmeterol

India Pharmaceutical Trade Intelligence

$72.8M148 Suppliers90 CountriesHS 30049099

ExportsIndia → CHILE13.4%India → TURKEY10.8%

#1 Supplier: CIPLA LIMITED #1 Buyer: PAYAZ BIOMEDIKAL

Salmeterol Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Salmeterol to the World

Between 2022 and 2026, India exported $72.8M worth of salmeterol across 7,006 verified shipments to 90 countries — covering 46% of world markets in the Respiratory & OTC segment. The largest destination is CHILE (13.4%). CIPLA LIMITED leads with a 76.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·HS 30049099

Salmeterol export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Salmeterol export data snapshot — $72.8M · 148 exporters · 90 countriesTransData Nexus · Indian Customs Data

Top Salmeterol Exporters from India

148 active exporters · Ranked by export value

View all 148 →

Top Salmeterol Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CIPLA LIMITED	$55.7M	1,265	44	76.5%
2	HETERO LABS LIMITED

Top Countries Importing Salmeterol from India

90 destination markets · Ranked by import value

All 90 countries →

Top Countries Importing Salmeterol from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	CHILE	$9.7M	13.4%
2	TURKEY	$7.9M	10.8%
3	AUSTRALIA	$7.6M	10.5%
4	MOROCCO	$5.8M	8.0%
5	BELGIUM	$5.2M	7.1%
6	UNITED ARAB EMIRATES	$3.9M	5.3%
7	SOUTH AFRICA	$3.8M	5.2%
8	SRI LANKA	$2.9M	4.0%
9	UNITED KINGDOM	$2.5M	3.4%
10	GERMANY	$2.4M	3.3%

CHILE is India's largest salmeterol export destination, absorbing 13.4% of total exports worth $9.7M. The top 5 importing countries — CHILE, TURKEY, AUSTRALIA, MOROCCO, BELGIUM — together account for 49.9% of India's total salmeterol export value. The remaining 85 destination countries collectively receive the other 50.1%, indicating a broadly diversified export footprint across multiple regions.

Salmeterol — Export Intelligence Video

Visual overview of India's salmeterol import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's salmeterol pharmaceutical import and export market — $72.8M in total trade, 148 verified manufacturers, and 90 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Salmeterol

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, salmeterol is approved for the treatment of asthma and COPD. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for salmeterol-containing products, indicating a competitive generic market. Notably, the original New Drug Application (NDA) for Serevent (salmeterol xinafoate inhalation) Diskus was approved on September 15, 1998. The regulatory pathway for salmeterol involves demonstrating bioequivalence to the reference listed drug, adherence to Good Manufacturing Practices (GMP), and compliance with labeling requirements. Given the presence of 148 active Indian exporters, it is imperative for these entities to ensure compliance with FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union, salmeterol is authorized for use in asthma and COPD management. The European Medicines Agency (EMA) has granted marketing authorizations for various salmeterol-containing products. For instance, Seffalair Spiromax received EU-wide approval on March 26, 2021. (ema.europa.eu) However, some products, such as BroPair Spiromax, had their marketing authorizations withdrawn on May 23, 2025, at the request of the marketing authorization holder for commercial reasons. (ema.europa.eu) Manufacturers exporting to the EU and UK must comply with EMA and Medicines and Healthcare products Regulatory Agency (MHRA) regulations, including obtaining marketing authorizations and adhering to EU GMP standards.

3WHO Essential Medicines & Global Standards

Salmeterol is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The WHO Prequalification Programme ensures that medicines meet global standards of quality, safety, and efficacy. Additionally, salmeterol formulations are standardized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), providing quality benchmarks for manufacturers and regulators.

4India Regulatory Classification

In India, salmeterol is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, specific ceiling prices for salmeterol are subject to periodic revisions. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for salmeterol have expired, leading to increased generic competition globally. This has facilitated the entry of multiple manufacturers into the market, contributing to the significant export activity from India.

6Recent Industry Developments

In June 2025, the EMA updated the product information for Seffalair Spiromax, reflecting new safety data. (ema.europa.eu) In December 2025, the EMA revised the product information for Bemrist Breezhaler, another inhalation product, to include updated safety and efficacy data. (ema.europa.eu) These developments highlight the dynamic nature of the regulatory landscape for inhalation therapies in the EU.

In summary, the regulatory landscape for salmeterol is characterized by established approvals in major markets, adherence to international quality standards, and a competitive environment due to patent expirations. Indian exporters must navigate these regulations diligently to maintain and expand their global market presence.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Salmeterol

Retail & reference prices across 9 markets vs. India FOB export price of $18.14/unit

Global Price Benchmark for Salmeterol across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.33	USD	According to the FDA Orange Book, salmeterol inhalation products are approved for use in the United States.
United Kingdom	Data not available	GBP	Salmeterol inhalation products are listed in the NHS Drug Tariff.
Germany	Data not available	EUR	Salmeterol inhalation products are regulated by the Federal Institute for Drugs and Medical Devices (BfArM).
Australia	Data not available

Supply Chain Risk Assessment — Salmeterol

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Salmeterol, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of these essential components are sourced from China, underscoring a significant dependency. This reliance exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or production issues within China.

In recent years, the Indian government has recognized this vulnerability and initiated measures to bolster domestic API and KSM production. The Production Linked Incentive (PLI) scheme, launched in 2020, aims to reduce dependence on imports by incentivizing local manufacturing. However, as of March 2026, the scheme's impact on decreasing reliance on Chinese imports remains limited, with the majority of raw materials still being sourced externally.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 reveals a high supplier concentration in Salmeterol exports from India. The top five exporters account for 92.5% of the total export value, with CIPLA LIMITED alone contributing 76.5% ($55.7 million). This significant concentration poses a single-source risk; any operational or regulatory issues affecting CIPLA LIMITED could substantially disrupt the global supply of Salmeterol.

Access Complete Salmeterol Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 7,006 transactions across 90 markets.

Request Demo View Pricing

Frequently Asked Questions — Salmeterol Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top salmeterol exporters from India?

The leading salmeterol exporters from India are CIPLA LIMITED, HETERO LABS LIMITED, MEDISPRAY LABORATORIES PRIVATE LIMITED, and 12 others. CIPLA LIMITED leads with 76.5% market share ($55.7M). The top 5 suppliers together control 92.5% of total export value.

What is the total export value of salmeterol from India?

The total export value of salmeterol from India is $72.8M, recorded across 7,006 shipments from 148 active exporters to 90 countries. The average shipment value is $10.4K.

Which countries import salmeterol from India?

India exports salmeterol to 90 countries. The top importing countries are CHILE (13.4%), TURKEY (10.8%), AUSTRALIA (10.5%), MOROCCO (8.0%), BELGIUM (7.1%), which together account for 49.9% of total export value.

What is the HS code for salmeterol exports from India?

The primary HS code for salmeterol exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Salmeterol

Salmeterol

Top Salmeterol Exporters from India

Top Countries Importing Salmeterol from India

Quick Facts

Related Respiratory & OTC

Related Analysis

Need Details?

Salmeterol — Export Intelligence Video

Regulatory Landscape — Salmeterol

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Salmeterol

Supply Chain Risk Assessment — Salmeterol

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Salmeterol Trade Intelligence

Frequently Asked Questions — Salmeterol Exports from India

Who are the top salmeterol exporters from India?

What is the total export value of salmeterol from India?

Which countries import salmeterol from India?

What is the HS code for salmeterol exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of salmeterol exports from India?

Which ports handle salmeterol exports from India?

Why is India a leading exporter of salmeterol?

What certifications do Indian salmeterol exporters need?

How many buyers import salmeterol from India?

What is the market share of the top salmeterol exporter from India?

Analysis Methodology